Hemostatic Agents Market 2019 Industry Outlook, Comprehensive Insights, Growth and Forecast 2025

The Hemostatic Agents Market in the Asia Pacific is expected to grow at a relatively higher CAGR. Baxter (the leading organization in the global market), plans to expand its operation in emerging nations such as India and China to enhance its accessibility. This is expected to propel the growth rate of the Asia Pacific hemostatic agents market. Meanwhile, the Europe market is likely to expand at a low CAGR due to the presence of a smaller patient pool compared to the Asia Pacific and North America.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/hemostatic-agents-market-100084

Combination Hemostats to Dominate the Global Market

In terms of product type, the combination hemostats segment accounted for 14% of the global market in 2017. Combination hemostats are proven to be very effective and offer faster healing. Combination hemostats are capable of offering efficient hemostasis in shorter time owing to the rapid action of thrombin and gelatin. Rising adoption of combination hemostats is anticipated to drive the global hemostatic agents market during the forecast period 2018-2025.

The factors expected to drive the global hemostatic agents market are increasing the incidence of hemorrhage during surgery and a rising emphasis on blood management. Moreover, innovations in a surgical procedure such as robot-assisted surgery and rising geriatric population are anticipated to fuel the demand in global hemostatic agents market.

As per data published by the Journal of Medical Emergency Services (JEMS), worldwide, approximately 5 million people die due to traumatic and non-traumatic hemorrhage. Therefore, the rising cases of traumatic or non-traumatic hemorrhage are likely to enable growth in the global hemostatic agents market.

Request Sample PDF @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hemostatic-agents-market-100084

The North America market was leading at a global sphere in the same year. According to the report, the trend is unlikely to change during the forecast period 2018-2025. Growth in the market witnessed in North America is attributable to the increasing demand for a surgical procedure in the region.

Baxter Widening its Distribution Network Across Regions

Baxter emerged dominant in the global hemostatic agents market in 2017. The growth witnessed is attributable to its diversification strategy implemented to improve the accessibility of its brands. The trend is unlikely to change and Baxter may continue to dominate the global market during the forecast period.

Strong brand presence, diversified product portfolio, and intense RandD conducted on hemostatic agents are a few factors contributing to Baster’s expansion

Besides this, as per research conducted by the American College of Obstetricians and Gynecologist, in the U.S. the rate of postpartum hemorrhage increased by 25.9% approximately during the last decade. This is likely to fuel the demand for hemostatic agents for surgery and other purposes

The report classifies the Global Hemostatic Agents Market in terms of various segments and offers a comprehensive overview. According to the report, the hemostatic agents market in North America was valued at US$ 1173 Mn in 2017.

Some of the Main Key Players Covered in the Report

  • Medtronic
  • Ethicon LLC.
  • Pfizer Inc.
  • Biom’up
  • Baxter International Inc.
  • Stryker
  • CryoLife Inc.
  • Integra Life Sciences
  • BD

Some of the other companies operating in the global hemostatic agents market are Stryker, CryoLife Inc., Integra Life Sciences, BD, Ethicon LLC., Pfizer Inc., Medtronic, and Biom’up.

Major Table of Content for Hemostatic Agents Market:

1.Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2.Executive Summary

3.Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4.Key Insights

4.1 Key strategies of leading market players

4.2 Technological advancements

4.3 Key mergers and acquisitions

4.4 Key performance indicators

5.Global Hemostatic Agents Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings/ Summary

5.2. Market Analysis,Insights and Forecast By Application

5.2.1Trauma

5.2.2Cardiovascular Surgery

5.2.3General Surgery

5.2.4Plastic Surgery

5.2.5Orthopedic Surgery

5.2.6Neurosurgery

5.2.7 Others

More Trending Topics from Future Business Insights:

Retinal Disease Therapeutics Market 2019: Company Profiles, Emerging Technologies, Trends, Industry Growth, Segments, Landscape and Demand by Forecast to 2025

Wound Care Devices Market,2019-2026, Research Report Analysis and Forecast | Smith and Nephew, Cardinal Health and more

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities

Contact us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]